Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
High costs may limit impact of weight loss drug semaglutide | Postoperative delirium after TAVR
Wednesday, September 6, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Weight loss drug semaglutide linked to better heart health, but high costs may limit its impact

It could cost more than $1 million just to avoid a single heart attack, stroke or cardiovascular death, researchers wrote. 

READ MORE >
money maze payment reimbursement
Share on Twitter Share on Facebook Share on Linkedin

Weight loss drug semaglutide linked to better heart health, but high costs may limit its impact

Share on Twitter Share on Facebook Share on Linkedin
money maze payment reimbursement
It could cost more than $1 million just to avoid a single heart attack, stroke or cardiovascular death, researchers wrote. 
READ MORE >

Delirium after TAVR: A common side effect linked to increased mortality

Temporary changes in cognition, including disorganized thinking, are seen in a significant number of patients following transcatheter aortic valve replacement. 

READ MORE >
stroke brain dementia alzheimer's puzzle mental health
Share on Twitter Share on Facebook Share on Linkedin

Delirium after TAVR: A common side effect linked to increased mortality

Share on Twitter Share on Facebook Share on Linkedin
stroke brain dementia alzheimer's puzzle mental health
Temporary changes in cognition, including disorganized thinking, are seen in a significant number of patients following transcatheter aortic valve replacement. 
READ MORE >

Featured Articles

FDA shares update on heart devices linked to multiple recalls and patient deaths

The devices, designed to provide temporary support to a patient's left ventricle, have been associated with a long list of issues in recent months. 

READ MORE >
Product Recall
Share on Twitter Share on Facebook Share on Linkedin

FDA shares update on heart devices linked to multiple recalls and patient deaths

Share on Twitter Share on Facebook Share on Linkedin
Product Recall
The devices, designed to provide temporary support to a patient's left ventricle, have been associated with a long list of issues in recent months. 
READ MORE >

Confirmed: Redo TAVR with balloon-expandable valves is safe and effective

The study, based on STS/ACC registry data, represents a collaboration between several leading TAVR specialists. 

READ MORE >
With advances and increased experience in the percutaneous coronary intervention (PCI), same-day discharge (SDD) has become increasingly commonplace, but patient selection is key. Antithrombotic therapy may not be necessary for certain transcatheter aortic valve replacement (TAVR) patients, according to a new analysis published in JACC: Cardiovascular Interventions.
Share on Twitter Share on Facebook Share on Linkedin

Confirmed: Redo TAVR with balloon-expandable valves is safe and effective

Share on Twitter Share on Facebook Share on Linkedin
With advances and increased experience in the percutaneous coronary intervention (PCI), same-day discharge (SDD) has become increasingly commonplace, but patient selection is key. Antithrombotic therapy may not be necessary for certain transcatheter aortic valve replacement (TAVR) patients, according to a new analysis published in JACC: Cardiovascular Interventions.
The study, based on STS/ACC registry data, represents a collaboration between several leading TAVR specialists. 
READ MORE >

In Case You Missed It

TAVR safe and effective for severe AS patients with a very low gradient

Yes, all-cause cause mortality is higher among TAVR patients with a very low baseline gradient, but the difference is almost entirely due to those patients presenting with more comorbidities. 

READ MORE >
A TAVR procedure being performed at Northwestern Medicine in Chicago.
Share on Twitter Share on Facebook Share on Linkedin

TAVR safe and effective for severe AS patients with a very low gradient

Share on Twitter Share on Facebook Share on Linkedin
A TAVR procedure being performed at Northwestern Medicine in Chicago.
Yes, all-cause cause mortality is higher among TAVR patients with a very low baseline gradient, but the difference is almost entirely due to those patients presenting with more comorbidities. 
READ MORE >

Missed opportunities: Many high-risk patients still not taking aspirin to prevent CVD

Aspirin is known to be an effective, affordable way to prevent cardiovascular disease.

READ MORE >
pills-384846_960_720.jpg
Share on Twitter Share on Facebook Share on Linkedin

Missed opportunities: Many high-risk patients still not taking aspirin to prevent CVD

Share on Twitter Share on Facebook Share on Linkedin
pills-384846_960_720.jpg
Aspirin is known to be an effective, affordable way to prevent cardiovascular disease.
READ MORE >

In Other News

Unavoidability of ‘one-off’ imaging forces radiology to keep one foot in fee-for-service world

Radiology can participate only sporadically in CMS’s current conception of value-based care. Why?

READ MORE >
Medicare alternative payment models fee for service value based care
Share on Twitter Share on Facebook Share on Linkedin

Unavoidability of ‘one-off’ imaging forces radiology to keep one foot in fee-for-service world

Share on Twitter Share on Facebook Share on Linkedin
Medicare alternative payment models fee for service value based care
Radiology can participate only sporadically in CMS’s current conception of value-based care. Why?
READ MORE >

23 healthcare workers arrested for protesting Kaiser Permanente staffing policies

The protesters were arrested for civil disobedience after organizing at the W Hollywood Hotel.

READ MORE >
depositphotos_7347703-stock-illustration-protesters-crowd-landscape-background-illustration.jpg
Share on Twitter Share on Facebook Share on Linkedin

23 healthcare workers arrested for protesting Kaiser Permanente staffing policies

Share on Twitter Share on Facebook Share on Linkedin
depositphotos_7347703-stock-illustration-protesters-crowd-landscape-background-illustration.jpg
The protesters were arrested for civil disobedience after organizing at the W Hollywood Hotel.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup